Michael Jareed Sherman

Michael Sherman practices at Eighth Street Dialysis in Washington, District of Columbia.

Michael Sherman's NPI, 1710144670, was assigned on May 19, 2008. Michael Sherman graduated from New York College of Osteo Medicine of New York Institute of Technology in 2003. Michael Sherman holds District of Columbia license DO034202.

Michael Sherman's primary practice is Eighth Street Dialysis, at 106 Irving NW St, Washington, DC 20010 in District Of Columbia County. The practice phone is (202) 399-0812.

Michael Sherman's primary practice is Eighth Street Dialysis in Washington, District of Columbia. Michael Sherman is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Michael Sherman to 3 more dialysis centers and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Sherman practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Michael Sherman's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Michael Sherman is licensed in District of Columbia.

CMS data shows 1,737 Medicare services from Michael Sherman across 10 procedure codes in 2024, for 497 Medicare patients. Medicare paid $193,756 for them.

CMS counts 497 Medicare patients who saw Michael Sherman in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 4.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Sherman's median patient age at 67, with 53% women.

In 2024, Michael Sherman wrote 1,135 Medicare Part D claims for 181 patients. 90% of them were for generic drugs. CMS names the drug for 903 of them, across 25 drugs with 11 or more claims each, at $78,781 in total drug cost. In 2023, CMS named 816 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Michael Sherman for performance year 2024, reported as part of a group. Michael Sherman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Sherman as offering telehealth.

CMS Open Payments shows 10 general payments to Michael Sherman from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Eli Lilly and Company paid the most, $74.

Michael Sherman graduated from New York College of Osteo Medicine of New York Institute of Technology in 2003.